Recent News

• 06.10.2025 - Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
• 02.27.2025 - Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand
• 02.04.2025 - Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
• 01.24.2025 - Gelteq Appoints Matthew Jones as Head of Sports Performance
• 12.19.2024 - Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
• 12.17.2024 - Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
• 12.17.2024 - Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
• 12.09.2024 - Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
• 12.02.2024 - Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
• 12.02.2024 - Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Recent Filings

• 03.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.15.2024 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 10.31.2024 - NT 20-F Notification of inability to timely file Form 20-F
• 10.30.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.30.2024 - EX-99.1 EX-99.1
• 10.28.2024 - CERT Certification by an exchange approving securities for listing
• 10.22.2024 - 424B4 Prospectus [Rule 424(b)(4)]